Treatment of phenothiazine-induced dyskinesia.
D014150:Antipsychotic Agents / Q000009:adverse effects*; D003533:Cyproheptadine / Q000627:therapeutic use*; D006801:Humans; D009069:Movement Disorders / Q000139:chemically induced / Q000188:drug therapy*; D010640:Phenothiazines
D014150:Antipsychotic Agents; D010640:Phenothiazines; D003533:Cyproheptadine